VSEE
VSEE HEALTH, INC.
+0.00 (+37.50%)0.02USD645K成交股數935K市值–本益比(近四季)0.1股價營收比+48.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.6M-53% | 3.2M-15% | 4.0M+19% | 1.1M-38% | 3.3M+105% | 3.7M+161% | 3.4M+164% | 1.7M+8% | 1.6M | 1.4M | 1.3M | 1.6M |
| 營業成本 | 1.4M | 2.0M | 1.9M | 440K | 1.5M | 1.4M | 941K | 487K | 386K | 478K | 474K | – |
| 毛利 | 206K-89% | 1.2M-50% | 2.1M-26% | 615K-21% | 1.9M+51% | 2.4M+150% | 2.8M+249% | 777K-22% | 1.2M | 954K | 797K | 1.0M |
| 毛利率 | 13.2% | 37.9% | 52.1% | 58.3% | 56.0% | 63.8% | 83.0% | 45.4% | 76.2% | 66.6% | 62.7% | 63.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.3M | 2.4M | 2.9M | 1.7M | 2.0M | 3.6M | 2.2M | 568K | 211K | 285K | 386K | 341K |
| 營業利益 | −2.7M+47% | −3.0M-2% | −2.1M-96% | −1.6M+67% | −1.8M-1860% | −3.0M+757% | −58.3M+8351% | −933K+30% | 104K | −353K | −690K | −716K |
| 營業利益率 | -172.7% | -94.1% | -51.7% | -147.5% | -55.1% | -81.1% | -1,737.8% | -54.5% | 6.4% | -24.6% | -54.3% | -45.4% |
| 稅後淨利 | – | −2.6M-19% | −290K-99% | −2.6M+312% | −4.0M-6408% | −3.2M+1591% | −53.9M+10613% | −634K+20% | 63K | −190K | −503K | −530K |
| 淨利率 | – | -82.3% | -7.3% | -247.7% | -119.2% | -85.9% | -1,607.5% | -37.0% | 3.9% | -13.2% | -39.6% | -33.6% |
| 稀釋 EPS | – | -0.05-97% | -0.02-99% | -0.16+33% | -0.24-2500% | -1.96+9700% | -3.58+3155% | -0.12+140% | 0.01 | -0.02 | -0.11 | -0.05 |
| 稀釋股數 | 53.7M | 47.9M | 16.5M | 16.4M | 16.3M | 10.2M | 15.1M | 5.3M | 4.6M | 10.0M | 4.6M | 4.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 454K | 1.3M | 473K | 292K | 410K | 326K | 2.3M | 1.1M | 724.00 | 507.00 | 31K | 16K |
| 應收帳款 | 2.2M | 2.7M | 2.6M | 1.6M | 1.9M | 1.7M | 1.0M | 923K | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 16.7M | 19.0M | 18.7M | 18.2M | 19.4M | 20.0M | 22.3M | 78.6M | 1.4M | 8.1M | 8.1M | 7.7M |
| 有息負債 | 782K | 782K | 589K | 594K | 594K | 594K | 594K | 594K | – | – | – | – |
| 總負債 | 9.1M | 12.7M | 24.3M | 23.9M | 22.9M | 20.0M | 21.4M | 25.5M | 5.6M | 5.0M | 9.4M | 3.9M |
| 股東權益 | 7.6M | 6.3M | −5.6M | −5.7M | −3.5M | −18K | 933K | 53.1M | −13.2M | −9.1M | −9.1M | −9.1M |
| 負債比 | 54.6% | 66.8% | 129.8% | 131.5% | 118.0% | 100.1% | 95.8% | 32.4% | 406.2% | 62.0% | 116.5% | 51.1% |
| 淨現金(現金 − 有息負債) | −327K | 565K | −117K | −302K | −184K | −268K | 1.7M | 512K | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.5M | – | – | −440K-176% | – | – | – | 579K | – | – | −341K |
| 資本支出 | – | 27K | – | – | 12K | – | – | – | 9K | – | – | – |
| 自由現金流 | – | −2.5M | – | – | −452K-179% | – | – | – | 571K | – | – | – |
| 折舊攤銷 | – | 647K | – | – | 647K | – | – | – | 618.00 | – | – | – |
| 買回庫藏股 | – | 50K | – | – | 0 | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -78.4% | – | – | -13.6% | – | – | – | 35.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 14.6M
| Technology | 7.4M | 50.5% | -10.1% |
|---|---|---|---|
| Telehealth | 7.2M | 49.5% | +226.6% |
產品／服務2025 年度 · 19.0M
| Telehealth Fees | 3.9M | 20.3% | +284.9% |
|---|---|---|---|
| Health Care Patient Service | 3.4M | 17.7% | +179.7% |
| Patient Fees | 3.4M | 17.7% | +179.7% |
| Subscription And Circulation | 3.2M | 17.0% | -21.5% |
| Professional Services And Other Fees | 3.1M | 16.3% | +47.2% |
| Technical Engineering Fees | 1.0M | 5.5% | -47.3% |
| Technology Service | 1.0M | 5.5% | -47.3% |
| Institutional Fees | 3K | 0.0% | -63.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 14.6M | – | −14.7M | -100.6% | -0.73 | −3.5M |
| FY2025 | – | – | – | –% | – | – |
| FY2024 | 10.4M | – | −57.7M | -553.7% | -5.65 | −5.8M |
| FY2024 | – | – | – | –% | – | – |
| FY2023 | 5.8M | – | −3.8M | -65.3% | -0.38 | −637K |
| FY2022 | – | – | −3.2M | –% | -0.25 | – |